← Eichor
Condition: Hemolytic Disease Of The Fetus And Newborn Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hemolytic Disease Of The Fetus And Newborn

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
Phase N/A · 1 location(s) · Institute of Mother and Child, Warsaw, Poland · NCT06984445A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Phase 3 · 62 location(s) · Janssen Research & Development, LLC · NCT05912517Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia
Phase 2 · 1 location(s) · National Institute of Blood and Marrow Transplant (NIBMT), P · NCT06490627A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
Phase N/A · 14 location(s) · Janssen Research & Development, LLC · NCT07194070Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · Abdullah Kutlar · NCT01245179
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.